Magnesium Chloride Sustained-Release Tablets and Promacta (Eltrombopag Powder for Suspension)
Determining the interaction of Magnesium Chloride Sustained-Release Tablets and Promacta (Eltrombopag Powder for Suspension) and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Eltrombopag and magnesium chloride should not be taken orally at the same time. Products that contain aluminum, calcium, iron, magnesium, zinc or other minerals may interfere with the absorption of eltrombopag into the bloodstream and reduce its effectiveness. You should take eltrombopag on an empty stomach at least 2 hours before or 4 hours after magnesium chloride. Talk to a healthcare professional if you are not sure whether a product contains something that could potentially interact with your medication or if you have questions on how to take this or other medications you are prescribed. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:ADJUST DOSING INTERVAL: Products containing aluminum, calcium, iron, magnesium, zinc and other polyvalent cations such as antacids or mineral supplements can significantly reduce the gastrointestinal absorption of eltrombopag due to chelation. In one clinical trial, administration of a single 75 mg dose of eltrombopag with an antacid containing 1524 mg aluminum hydroxide and 1425 mg magnesium carbonate resulted in an approximately 70% decrease in eltrombopag peak plasma concentration (Cmax) and systemic exposure (AUC).
MANAGEMENT: Eltrombopag should be taken on an empty stomach at least 2 hours before or 4 hours after oral medications that contain antacids (e.g., didanosine buffered tablets or pediatric oral solution), aluminum, calcium, iron, magnesium, zinc or other polyvalent cations.
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
- "Product Information. Promacta (eltrombopag)." GlaxoSmithKline, Research Triangle Park, NC.
Generic Name: magnesium chloride
Brand name: Chloromag, Slow-Mag, Mag 64, MagDelay, Mag-SR
Synonyms: Magnesium chloride (injection), Magnesium Chloride
Generic Name: eltrombopag
Brand name: Promacta
Synonyms: Promacta
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Magnesium Chloride Sustained-Release Tablets-Promacta (Eltrombopag Tablets)
- Magnesium Chloride Sustained-Release Tablets-Promethazine
- Magnesium Chloride Sustained-Release Tablets-Promethazine and Phenylephrine
- Magnesium Chloride Sustained-Release Tablets-Promethazine Hydrochloride
- Magnesium Chloride Sustained-Release Tablets-Promethazine injection
- Magnesium Chloride Sustained-Release Tablets-Promethazine Injection, Intravenous
- Promacta (Eltrombopag Powder for Suspension)-Magnesium citrate
- Promacta (Eltrombopag Powder for Suspension)-Magnesium Citrate Liquid
- Promacta (Eltrombopag Powder for Suspension)-Magnesium gluconate
- Promacta (Eltrombopag Powder for Suspension)-Magnesium hydroxide
- Promacta (Eltrombopag Powder for Suspension)-Magnesium Hydroxide and Mineral Oil
- Promacta (Eltrombopag Powder for Suspension)-Magnesium Hydroxide Chewable Tablets